Targeting ferroptosis in hepatocellular carcinoma

被引:14
|
作者
Mo, Yuqian [1 ]
Zou, Zhilin [2 ]
Chen, Erbao [3 ]
机构
[1] Guangdong Med Univ, Sch Publ Hlth, Zhanjiang 524023, Guangdong, Peoples R China
[2] Wenzhou Med Univ, Affiliated Eye Hosp, Dept Ophthalmol, Wenzhou, Zhejiang, Peoples R China
[3] Peking Univ, Shenzhen Hosp, Dept Hepatobiliary & Pancreat Surg, Shenzhen 518036, Guangdong, Peoples R China
关键词
Ferroptosis; Hepatocellular carcinoma; Immunotherapy; Immune microenvironment; SUPPRESSOR-CELLS; LIPID-PEROXIDATION; T-CELLS; 1ST-LINE TREATMENT; CANCER; DYSFUNCTION; SORAFENIB; ZIP14; TRANSPORTER; SENSITIVITY;
D O I
10.1007/s12072-023-10593-y
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is a common malignant tumor with complex survival mechanism and drug resistance, resulting in cancer-related high mortality in the world. Ferroptosis represents a form of regulated cell death, typically distinguished by iron-dependent lipid peroxidation. Cancer cells often employ antioxidant defenses to evade the harmful effects of excess iron. Recent research has proposed that directing interventions towards ferroptosis could serve as an effective strategy in curbing the proliferation and invasion of HCC. Immunotherapy has made some preliminary progress in the remodeling of immune microenvironment, but it has not completely inhibited HCC growth, invasion and drug resistance. Furthermore, ferroptosis is widely observed in the formation of immune microenvironment of HCC and mediates the response of many targeted drugs and immunotherapy. Clarifying the role of ferroptosis in these complex processes is expected to provide a new prospect for HCC treatment. In this review, we outline the mechanisms by which HCC develops invasiveness and drug resistance by evading iron-dependent death, and paint a comprehensive landscape of ferroptosis in different cell types in the HCC immune microenvironment.
引用
收藏
页码:32 / 49
页数:18
相关论文
共 50 条
  • [21] Current Progress of Ferroptosis Study in Hepatocellular Carcinoma
    Zhu, Xinyue
    Sha, Xudong
    Zang, Yan
    Ren, Qiaohui
    Zhang, Shubing
    Ma, Dongyue
    Wang, Lianzi
    Yao, Junxiao
    Zhou, Xinyi
    Yu, Li
    Li, Tao
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2024, 20 (09): : 3621 - 3637
  • [22] Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy
    Ajoolabady, Amir
    Tang, Daolin
    Kroemer, Guido
    Ren, Jun
    BRITISH JOURNAL OF CANCER, 2023, 128 (02) : 190 - 205
  • [23] Ferroptosis and hepatocellular carcinoma: the emerging role of lncRNAs
    Chen, Haoran
    Han, Zhongyu
    Su, Junyan
    Song, Xuanliang
    Ma, Qingquan
    Lin, Yumeng
    Ran, Zijin
    Li, Xueping
    Mou, Rongkun
    Wang, Yi
    Li, Dongxuan
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [24] Ferroptosis in hepatocellular carcinoma: from bench to bedside
    Tang, Daolin
    Kroemer, Guido
    Kang, Rui
    HEPATOLOGY, 2024, 80 (03) : 721 - 739
  • [25] Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy
    Amir Ajoolabady
    Daolin Tang
    Guido Kroemer
    Jun Ren
    British Journal of Cancer, 2023, 128 : 190 - 205
  • [26] Scutellaria barbata Inhibits Hepatocellular Carcinoma Tumorigenicity by Inducing Ferroptosis of Hepatocellular Carcinoma Cells
    Li, Yue
    Zhang, Jiongshan
    Zhang, Kun
    Chen, Yan
    Wang, Wei
    Chen, Hongjie
    Zou, Zengcheng
    Li, Yongwei
    Dai, Min
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Cyclovirobuxine D inhibits hepatocellular carcinoma growth by inducing ferroptosis of hepatocellular carcinoma cells
    Jiang, Xinru
    Li, Hongdan
    Liu, Yang
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [28] Cyclovirobuxine D inhibits hepatocellular carcinoma growth by inducing ferroptosis of hepatocellular carcinoma cells
    Xinru Jiang
    Hongdan Li
    Yang Liu
    Discover Oncology, 15
  • [29] Glycyrrhizic acid attenuates sorafenib resistance by inducing ferroptosis via targeting mTOR signaling in hepatocellular carcinoma
    Hu, Yiting
    Luo, Zhongfei
    Cai, Siyi
    Xie, Qinfen
    Zheng, Shusen
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2024, 59 (06) : 730 - 736
  • [30] Targeting integrins in hepatocellular carcinoma
    Wu, Yanhua
    Qiao, Xiaojing
    Qiao, Shouyi
    Yu, Long
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (04) : 421 - 437